Drawing for MTF BIOLOGICS. SCIENCE DRIVEN. PATIENT FOCUSED.

USPTO serial 87979442

MTF BIOLOGICS. SCIENCE DRIVEN. PATIENT FOCUSED.

Reviewed by CopyMark Law Group

Reg. 5676732Status 702Registered
Filing date
Status date
Registration date
Feb 12, 2019
Examiner
DINALLO, KEVIN M
Law office
FILE DESTROYED

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with MTF BIOLOGICS. SCIENCE DRIVEN. PATIENT FOCUSED.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William W. Stroever

William W. Stroever Cole Schotz P.C.25 Main StreetHackensack, NJ 07601United States

Goods and services

ClassDescriptionStatusFirst use
005Allograft material, namely, processed human bone and tissue for use in surgical or medical procedures; Allograft material, namely, human bone and tissue processed into implants, scaffolds, powders, gels, pastes, putty, mats, films, strips, sheets, molded pieces, surgical patches, plugs, wound dressings, or wound coverings; Growth factors, namely, proteins for promoting tissue growth and repair, processed into surgical implants, scaffolds and plugs for the repair and replacement of human bone and tissue defects; Processed acellular human dermis and fascia tissue intended for subsequent implantation or for use in cosmetic surgery; Human allograft tissue derived from dermis; Human allograft tissue for topical use comprised of tissue from placental membranes; Human allograft tissue derived from placental tissue; Human allograft tissue derived from adipose matrix; Adipose cavity filler; Soft tissue implant for use in surgery; Bone void fillers consisting of biological materials; Bone void fillers consisting of natural materials; Cartilage implants derived from living tissue; Hydrated packaging containers specially designed for transporting and holding allograft implants made from living tissue and boneACTIVE—
040Human allograft tissue processing services, namely, preparing biological tissue for subsequent implantation in the human bodyACTIVE—
044Human allograft tissue bank donor services; Maintaining files and records concerning the donation of human tissue between and among the hospital, donor and recipient; Medical services in the field of human tissue, cells, bone and organ donations, namely, obtaining donor consent and human donor referrals, conducting donor screening surveys, collecting donor medical data, coordinating donor recoveries with outside entities, and providing statistical donor data to othersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 10, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Sep 10, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Sep 10, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 26, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Feb 12, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 12, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 10, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jan 9, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 8, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 7, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 7, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 4, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 4, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 4, 2019CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 27, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Dec 27, 2018DPCCDIVISIONAL PROCESSING COMPLETE—
Dec 20, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 28, 2018IUAFUSE AMENDMENT FILED—
Nov 28, 2018DRRRDIVISIONAL REQUEST RECEIVED—
Nov 28, 2018ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Nov 28, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 20, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 18, 2018EX1GSOU EXTENSION 1 GRANTED—
Jun 18, 2018EXT1SOU EXTENSION 1 FILED—
Jun 18, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 3, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 3, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 19, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 24, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 24, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 4, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 18, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 18, 2017ALIEASSIGNED TO LIE—
Sep 5, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 5, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Sep 5, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 5, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 5, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 1, 2017PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Sep 1, 2017AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Aug 29, 2017DOCKASSIGNED TO EXAMINER—
Jun 7, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 3, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance